Skip to content

Other segment segments

Core Nutritional
$60.75M
Hiya
$24.77M+5.4%

Similar metrics at other companies

Ulta Beauty, Inc. logo
ULTASG&A
$814.7M+14.6%
ImmunityBio, Inc. logo
IBRXReportable Segment — SG&A
$45.77M+40.2%
PepsiCo logo
PEPSG&A
$7.52B+1.5%
Madrigal Pharmaceuticals, Inc. logo
MDGLSG&A
$268.52M+60.0%
BridgeBio Pharma logo
BBIOReportable Segment — SG&A
$163.9M+54.1%
Element Solutions logo
ESISG&A
$191.1M+21.6%

Other financials

Income statement

See full
Revenue$250.2M+0.3%
Gross profit$190.8M-3.2%
Operating income$13.9M-11.5%
Net income$7.5M-20.1%
EPS (diluted)$0.41-16.3%

Balance sheet

See full
Cash & equivalents$165.7M-9.2%
Total debt$18.0M+10.8%
Total equity$543.6M+2.6%
Total assets$739.0M-1.0%

Cash flow

See full
Operating cash flow$9.8M-37.0%
CapEx$2.6M-5.6%
Free cash flow$7.1M-43.9%

Valuation

See full
Market cap$363.35M-36.1%
P/E18.1×+7.8×
P/S0.4×-0.3×

Profitability

See full
Gross margin77.6%-3.0pp
Operating margin3.8%-2.7pp
Net margin1.9%-4.4pp
FCF margin5.7%-1.1pp

Returns & leverage

See full
Return on equity3.2%-7.6pp
Debt / equity0.0×
Current ratio2.5×+0.5×

Where this comes from

Reported directly by USANA Health Sciences in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about USANA Health Sciences's rise — sg&a.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is USANA Health Sciences's rise — SG&A?
USANA Health Sciences (USNA) reported rise — SG&A of $2.74M in Q1 2026.
What does rise — SG&A mean?
Includes the operating expenses, such as marketing, administrative support, and overhead, specifically allocated to the Rise segment. It provides insight into the operational costs required to support and grow this specific business unit.